 Study E7080-C086-108 is an open-label, single- and multiple-dose pharmacokinetic PK study of lenvatinib administered orally, once a day QD in Chinese participants with solid tumor. A total of 12 participants will be enrolled to evaluate the PK of 24 milligrams mg QD dosing of lenvatinib. 